CEO John Seifert and next generation leader Carina De Blois talk about Ogilvy’s future and how it fits into the ever-morphing industry.
Weight Watchers is changing its name to WW and adopting a new tagline, “Wellness that works”, as it responds to changing views on healthy lifestyles.
Amarin prescription fish oil beats expectations in clinical trial; Farxiga meets primary endpoints; Weight Watchers rebrands.
Burrell has spent more than 20 years of her career at pharma companies.
Federal prosecutors investigate pharma kickbacks; FDA to fast-track e-cigarette designed to curb teen use; Medtronic to acquire Mazor Robotics.
For an industry hungry for ethical role models who transcend our fragmented healthcare system, a new book brings Elie Wiesel’s legacy into focus.
The drugmaker has refocused on ethics to move past the Michael Cohen scandal.
Outgoing Pharmaceutical Care Management Association chief executive Mark Merritt is stepping down after 15 years.
Amicus acquires rare disease gene therapy programs; Data shows black patients are underrepresented in clinical trials; Takeda acquires Molecular Templates.
Nicola Kayel, VP, GI marketing at Salix Pharmaceuticals, discusses how she stays organized, what her day looks like, and what she’s reading.